Research / CVV / Fundamental state Inspectable configuration
State dimensions Filing 0001641172-25-023180 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
4.40% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.08% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-62.02% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
-19.45% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
45.55% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
20.99% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-22.30% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
13.42% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
4.89% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 12 states History building
Sep 30, 2023 0/8 normalized Level 3 Dec 31, 2023 0/8 normalized Level 3 Mar 31, 2024 0/8 normalized Level 3 Jun 30, 2024 0/8 normalized Level 3 Sep 30, 2024 0/9 normalized Level 3 Dec 31, 2024 0/9 normalized Level 3 Mar 31, 2025 0/9 normalized Level 3 Jun 30, 2025 0/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 3 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 2.97%
Current 4.40%
Delta 1.43% Capex Intensity Decreased
Previous 0.54%
Current 0.08%
Delta -0.46% Cash Generation Decreased
Previous -27.20%
Current -62.02%
Delta -34.82% Growth Decreased
Previous 68.96%
Current -19.45%
Delta -88.40% Inventory Pressure Increased
Previous 24.49%
Current 45.55%
Delta 21.05% Margin Decreased
Previous 32.41%
Current 20.99%
Delta -11.41% Profitability Decreased
Previous 3.23%
Current -22.30%
Delta -25.54% R And D Intensity Increased
Previous 9.39%
Current 13.42%
Delta 4.03% Sbc Intensity Increased
Previous 3.17%
Current 4.89%
Delta 1.72% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.